Detailed review for COVID-19 tx budget are insufficient

Welfare Committee's Special Committee on Budget and Accounts resolution, lack of evidence, raised the possibility of reduction of the committee

Vaccine cold chain and clinical advancement, etc. budget reflected, including flu NIP

The National Assembly's Health and Welfare Committee was found to have insufficient details of the detailed review of the new budget of ₩965 billion, which accounted for the largest volume of the COVID-19-related budget, before the resolution of the budget under its jurisdiction next year.

 

Although it accounts for the highest budget among health budgets, not welfare, the specific direction of how to spend ₩965 billion on securing COVID-19 treatments and vaccines in the future has not been reviewed, so it may be mistaken as a poor review.

 

As a result of reviewing the budget bill decided by the Special Committee on Budget and Accounts of the Welfare Committee on the 10th, the 'COVID-19 Treatment and Vaccine Acquisition' project in the General Account of the Korea Disease Control and Prevention Agency's Medical Safety and Prevention Bureau is planned to use a detailed budget.

 

The need for the budget was pointed out by Kiyoon Kang, a member of People Power Party.

 

He requested a new formation of ₩965 billionn in the budget for securing treatments and vaccines.

 

The Korea Disease Control and Prevention Agency expressed its position of 'partial acceptance', saying that advanced review is necessary in consideration of the COVID-19 outbreak situation, and the preliminary subcommittee recognized the necessity in the screening and decided to organize a new program of ₩965 billion.

 

The budget will be reviewed by the Special Committee on Budget and Accounts after going through the plenary session of the welfare committee.

 

The problem is that although it occupies the largest portion of the health budget for next year, the specific direction of how and where to spend the future budget has not been examined.

 

In the future, it is impossible to know the direction of the detailed budget at all, whether the budget is to be used for free vaccination by investing a budget of ₩965 billion for the national vaccination project for COVID-19 treatment and vaccines, or to support domestic and foreign pharmaceutical companies that are needed for domestic supply and demand of treatments and vaccines.

 

In this case, even if it is judged by the Special Committee on Budget and Accounts, there is a greater possibility that the Strategy & Finance Committee will refuse to reflect the budget because it does not recognize the validity.

 

This is because there is a low justification for accommodating the budget of around ₩1 trillion without a specific reason.

 

A member of the Welfare Committee's Special Committee on Budget and Accounts said, "There is no way to confirm the details of the relevant budget review and future directions," adding to the question.

 

The noticeable budget is an advanced flu vaccine cold chain system that has revealed problems in the process of preventing COVID-19 Twindemic.

 

Democratic Party of Korea Rep.

 

Seo Young-suk insisted on an increase of ₩300 million in the new budget for advanced cold chain systems in the MFDS budget.

 

Since it is necessary to introduce a temperature change system for each stage of distribution and storage after exposure to the vaccine at room temperature, the opinion is to increase the 'Intelligent Cold Chain System Introduction Research Service Budget' by ₩300 million.

 

The MFDS also announced its acceptance of the budget and has been voted for.

 

Democratic Party of Korea, Hyun-young Shin also requested an increase of ₩100 million from the national vaccination budget for the investigation of the cold chain of vaccine distribution in the budget of the Korea Disease Control and Prevention Agency.

 

The Korea Disease Control and Prevention Agency also plans to accept the budget to investigate the distribution and storage of vaccines that are important to the NIP.

 

In the MOHW's budget, a new budget of ₩2.5 billion was accepted to support the development of new drugs targeting COVID-19, solve the problem of discontinued research, and support linkage to follow-up projects.

 

The details are the ₩1.5 billion for new drug development and ₩1 billion for the drug recycling budget using the drug repositioning strategy.

 

Ho-young Joo, Seo Jeong-sook and Paik Jong-heon , members of People Power Party requested.

 

Democratic Party of Korea, Seong-ju Kim and Lee In-geun were voted for an increase of ₩2 billion in the budget for establishing a clinical trial support system to support rapid development of infectious disease treatments and vaccines.

 

Seong-ju Kim, Lee In-geun, and Nam In-soon also requested an increase of ₩1.5 billion in the budget to establish the basis for advancement of clinical trials, and the detailed budget plan is to establish a clinical platform for infectious diseases, foster clinical experts, and introduce a clinical trial center.

 

Nam In-soon also requested an increase of ₩500 million in the clinical research budget for oriental medicine standard guidelines for the creation of an oriental medicine basis and ₩500 million for the support of the establishment of a clinical infrastructure for oriental medicine from the budget for developing oriental medicine leading technology.

 

In The MFDS budget, Democratic Party of Korea Kang Byungwon, Ko Young-in, Kim Seong-ju, Kim Won-i, Nam In-soon, Shin Hyun-young, Seo Young-suk, and People Power Party Lee Jong-seong requested an increase in the budget for strengthening clinical trial safety standards by ₩5,316 million.

 

The budget is based on a joint review committee for integrated review of multi-center clinical trial plans, a customized clinical helper center for patients, and DSUR data evaluation management.

 

Democratic Party of Korea Choi Hye-young and People Power Party Lee Jong-seong also requested an increase of ₩4.2 billion in budget for approval and approval from the MFDS.

 

It is a business that operates audit personnel by using the licensing fee as an income replacement expense.

 

Details include ₩3,040 million for expansion of the audit personnel, ₩100 million for office rental, ₩265 million for examination-related goods, and ₩795 million for examination advisory expenses.

 

.Democratic Party of Korea Choi Hye-young requested a new budget of ₩1.45 billion to improve accessibility for people with disabilities in drug safety information

 

.The budget is based on the development of labeling methods and standards such as Braille on pharmaceutical packaging, research on labeling systems, education and public relations, survey and evaluation, and labor costs for six personnel at the KIDS

 

.People Power Party Bong-min Jeon asked for ₩1 billion increase in the budget to expand the promotion of the drug side effects damage relief system

 

.It is based on the expansion of publicity such as terrestrial advertisements, radio advertisements, and outdoor media

 

.The Korea Disease Control and Prevention Agency's budget is the largest increase in the national vaccination budget for the prevention of COVID-19 Twindemic, along with the new budget of ₩965 billion for COVID-19 treatment and vaccine acquisition

 

.Specifically, People Power Party Kiyoon Kang, Miae Kim, Jongheon Baek, and Hoyoung Joo requested an increase in the national expansion budget for flu vaccination by ₩274.6 billion, and the Korea Disease Control and Prevention Agency made some acceptance positions

 

.Democratic Party of Korea Kang Byungwon, Kim Seong-ju, Kim Won-i, Nam In-soon, Shin Hyun-young, Heo Jong-sik, Ko Young-in, and Lee Yong-ho ( nonpartisan representative) requested an increase of ₩80.7 billion to expand flu vaccinations for those aged 14-18 and 62-64

 

.Democratic Party of Korea Yeong-Seok Seo also proposed an increase in flu vaccination budget for the ages 14-18 and 62-64 to increase by ₩41.4 billion, and Chung Chun-suk by ₩17.2 billion for 14-18 years old

 

.People Power Party Kang Ki-yoon, Kim Mi-ae, and Paik Jong-heon called for an increase of ₩246.4 billion in the budget to add 23-valent polysaccharide vaccines and 13-valent protein-conjugated vaccines to the scope of support for the pneumococcal vaccination project over the age of 65

 

.Democratic Party of Korea Seo Young-seok and Choi Hye-young also proposed an increase in budget of ₩7.2 billion to support 13-valent protein-coupled pneumococcal vaccine for high-risk groups among the elderly over 65

 

.Democratic Party of Korea Choi Hye-young and Seo Young-suk demanded an increase of ₩100.9 billion in budget for the expansion of the human papillomavirus (HPV) vaccination program for 12-year-old girls

 

.In addition to cervical cancer, the HPV vaccine is effective for men as it has the effect of preventing anal cancer and penile cancer, and it is pointed out that men also need vaccination to prevent men from passing the virus to women

 

.The Korea Disease Control and Prevention Agency was in a difficult position to accept because of the cost-effectiveness of expanding boys, the effect of preventing infectious diseases, and reviewing public health priorities

 

.The Welfare Committee is expected to hold a plenary meeting on the 17th and decide on a budget under the jurisdiction for next year, which has been preliminary reviewed by the Special Committee on Budget and Accounts

 

.The budget proposal is finalized when it passes the plenary session after the preliminary committee's review.